XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 30, 2022   323,951      
Beginning balance at Dec. 30, 2022 $ 2,488,427 $ 324 $ 2,536,849 $ (14,521) $ (34,225)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 40,028       40,028
Other comprehensive income (loss) 5,232     5,232  
Issuance of common stock under equity incentive plans (in shares)   1,034      
Issuance of common stock under equity incentive plans 7,080 $ 1 7,079    
Stock transactions associated with taxes withheld on equity awards (2,523)   (2,523)    
Stock-based compensation 16,892   16,892    
Ending balance (in shares) at Mar. 31, 2023   324,985      
Ending balance at Mar. 31, 2023 $ 2,555,136 $ 325 2,558,297 (9,289) 5,803
Beginning balance (in shares) at Dec. 29, 2023 302,793 302,793      
Beginning balance at Dec. 29, 2023 $ 2,263,912 $ 303 2,440,710 (3,750) (173,351)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 37,317       37,317
Other comprehensive income (loss) (1,454)     (1,454)  
Issuance of common stock under equity incentive plans (in shares)   877      
Issuance of common stock under equity incentive plans 8,438 $ 1 8,437    
Stock transactions associated with taxes withheld on equity awards (6,994)   (6,994)    
Repurchases of common stock (in shares)   (8,638)      
Repurchases of common stock (192,541) $ (9) (69,618)   (122,914)
Stock-based compensation $ 19,330   19,330    
Ending balance (in shares) at Mar. 29, 2024 295,032 295,032      
Ending balance at Mar. 29, 2024 $ 2,128,008 $ 295 $ 2,391,865 $ (5,204) $ (258,948)